Logo image of FNCH

FINCH THERAPEUTICS GROUP INC (FNCH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FNCH - US31773D2009 - Common Stock

1.8 USD
-0.18 (-9.09%)
Last: 5/24/2024, 8:00:00 PM
1.8001 USD
+0 (+0.01%)
After Hours: 5/24/2024, 8:00:00 PM
Fundamental Rating

3

Overall FNCH gets a fundamental rating of 3 out of 10. We evaluated FNCH against 525 industry peers in the Biotechnology industry. While FNCH seems to be doing ok healthwise, there are quite some concerns on its profitability. FNCH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • FNCH had negative earnings in the past year.
  • FNCH had a negative operating cash flow in the past year.
  • In the past 5 years FNCH always reported negative net income.
  • In the past 5 years FNCH always reported negative operating cash flow.
FNCH Yearly Net Income VS EBIT VS OCF VS FCFFNCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -32.51%, FNCH is in the better half of the industry, outperforming 67.18% of the companies in the same industry.
  • FNCH has a Return On Equity (-85.55%) which is in line with its industry peers.
Industry RankSector Rank
ROA -32.51%
ROE -85.55%
ROIC N/A
ROA(3y)-77.06%
ROA(5y)-55%
ROE(3y)-158.4%
ROE(5y)-105.73%
ROIC(3y)N/A
ROIC(5y)N/A
FNCH Yearly ROA, ROE, ROICFNCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -100 -200 -300

1.3 Margins

  • FNCH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FNCH Yearly Profit, Operating, Gross MarginsFNCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -20K -40K -60K

More info and screens

6

2. Health

2.1 Basic Checks

  • FNCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for FNCH has been increased compared to 1 year ago.
  • FNCH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FNCH Yearly Shares OutstandingFNCH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 500K 1M 1.5M
FNCH Yearly Total Debt VS Total AssetsFNCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

  • FNCH has an Altman-Z score of -10.91. This is a bad value and indicates that FNCH is not financially healthy and even has some risk of bankruptcy.
  • FNCH has a Altman-Z score of -10.91. This is in the lower half of the industry: FNCH underperforms 78.76% of its industry peers.
  • FNCH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.91
ROIC/WACCN/A
WACC4.16%
FNCH Yearly LT Debt VS Equity VS FCFFNCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 6.05 indicates that FNCH has no problem at all paying its short term obligations.
  • FNCH has a Current ratio of 6.05. This is in the better half of the industry: FNCH outperforms 60.79% of its industry peers.
  • FNCH has a Quick Ratio of 6.05. This indicates that FNCH is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of FNCH (6.05) is better than 61.14% of its industry peers.
Industry RankSector Rank
Current Ratio 6.05
Quick Ratio 6.05
FNCH Yearly Current Assets VS Current LiabilitesFNCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M

More info and screens

3

3. Growth

3.1 Past

  • FNCH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.38%, which is quite impressive.
  • The Revenue for FNCH has decreased by -100.00% in the past year. This is quite bad
  • The Revenue for FNCH have been decreasing by -75.98% on average. This is quite bad
EPS 1Y (TTM)89.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.8%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-75.98%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • FNCH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 507.50% yearly.
EPS Next Y45.96%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y2874.9%
Revenue Next 3Y1411.62%
Revenue Next 5Y507.5%

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FNCH Yearly Revenue VS EstimatesFNCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
FNCH Yearly EPS VS EstimatesFNCH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -20 -40 -60

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FNCH. In the last year negative earnings were reported.
  • Also next year FNCH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FNCH Price Earnings VS Forward Price EarningsFNCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FNCH Per share dataFNCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • FNCH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FINCH THERAPEUTICS GROUP INC / FNCH FAQ

What is the fundamental rating for FNCH stock?

ChartMill assigns a fundamental rating of 2 / 10 to FNCH.


What is the valuation status for FNCH stock?

ChartMill assigns a valuation rating of 0 / 10 to FINCH THERAPEUTICS GROUP INC (FNCH). This can be considered as Overvalued.


What is the profitability of FNCH stock?

FINCH THERAPEUTICS GROUP INC (FNCH) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for FNCH stock?

The Earnings per Share (EPS) of FINCH THERAPEUTICS GROUP INC (FNCH) is expected to grow by 45.96% in the next year.